Get the best experience on mobile
Join 5K+ users on Alpha Tribe
ZIM LABS board approved Q3 & nine-month consolidated financial results, with revenue at ₹108.66 Cr & PAT at ₹4.40 Cr. The board also greenlit investing up to USD 15,000 to form a new wholly-owned subsidiary in Chile for LATAM region expansion.
Comments
All announcements from Zim Laboratories Limited